Global Human Microbiome Market Size, Trends & Growth Opportunity by Product (Prebiotic, Probiotic, Food, Medical Food, Drug), Application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological), Research Technology (Proteomics, Metabolomics), Region and Forecast till 2027>
Global Human Microbiome Market
The Global Human Microbiome Market is estimated to be USD 599 Mn in 2021 and is projected to reach USD 3,127.91 Mn by 2027, growing at a CAGR of 21.75 %. human microbiota is known as human tissues are covered with millions of microorganisms such as viruses, bacteria, and fungi. microbiome is called as all the genes present inside these organisms. Human microbiomes play an important role in advanced healthcare, as it enables to allow easy digestion of food, production of vitamins such as Vitamin K, B, and B12 which is important for blood coagulation.
Market Drivers
The increase in incidence of lifestyle diseases and the rise in focus on human microbiome therapies is expected to boost the global human microbiome market growth over the forecast period. Further, the rise in technological advancements in meta-genomics and next-generation sequencing will positively influence the global human microbiome market. Also, the rise in aging population will drive the market growth. In addition to that, the rise in partnership, collaboration, and mergers and acquisition activities by key operating players will propel the global human microbiome market growth over the forecast period.
Market Restraints
Lack of qualified personnel and detailed research is the major restraint which is expected to hinder the global human microbiome market. Also, stringent government regulations will limit the global human microbiome market growth during this forecast timeline.
Market Segmentation
The Global Human Microbiome Market is segmented into Product such as Prebiotic, Probiotic, Food, Medical Food, and Drug. Further market is segmented into application (Therapeutic), Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological), and Research Technology (Proteomics, and Metabolomics)
Also, Global Human Microbiome Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market key Players
Various key players are discussed in the global human microbiome market report including Enterome, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Synthetic Biologics, Inc, DuPont, BiomX Ltd, MaaT Pharma, and Eligo Bioscience.
Market Taxonomy
By Product
- Prebiotic
- Probiotic
- Food
- Medical Food
- Drug
- Therapeutic
- Disease
- Infectious
- Metabolic/Endocrine
- Cancer
- Blood
- Neurological
- Research Technology
- Proteomics
- Metabolomics
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- What are the Key Opportunities in Global Human Microbiome Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
- What are the strategies adopted by key players?
- >1 Introduction
- 1.1 Objective of the Study
- 1.2 Market definition
- 1.3 Market Scope
- 2 Research Methodology
- 2.1 Data Mining
- 2.2 Validation
- 2.3 Primary Interviews
- 2.4 List of Data Sources
- 3 Executive Summary
- 4 Global Human Microbiome Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Human Microbiome Market, By Product
- 5.1 Y-o-Y Growth Comparison, By Product
- 5.2 Global Human Microbiome Market Share Analysis, By Product
- 5.3 Global Human Microbiome Market Size and Forecast, By Product
- 5.3.1 Prebiotic
- 5.3.2 Probiotic
- 5.3.3 Food
- 5.3.4 Medical Food
- 5.3.5 Drug
- 6 Global Human Microbiome Market, By Application
- 6.1 Y-o-Y Growth Comparison, By Application
- 6.2 Global Human Microbiome Market Share Analysis, By Application
- 6.3 Global Human Microbiome Market Size and Forecast, By Application
- 6.3.1 Therapeutic
- 6.3.2 Disease (Infectious, Metabolic/Endocrine, Cancer, Blood, Neurological)
- 6.3.3 Research Technology (Proteomics, Metabolomics)
- 7 Global Human Microbiome Market, By Region
- 7.1 Global Human Microbiome Market Share Analysis, By Region
- 7.2 Global Human Microbiome Market Share Analysis, By Region
- 7.3 Global Human Microbiome Market Size and Forecast, By Region
- 8North America Human Microbiome Market Analysis and Forecast (2022 – 2027)
- 8.1 Introduction
- 8.2 North America Human Microbiome Market Share Analysis, By Product
- 8.3 North America Human Microbiome Market Size and Forecast, By Application
- 8.4 North America Human Microbiome Market Size and Forecast, By Country
- 8.4.1 U.S
- 8.4.2 Canada
- 8.4.3 Mexico
- 9Europe Human Microbiome Market Analysis and Forecast (2022 – 2027)
- 9.1 Introduction
- 9.2 Europe Human Microbiome Market Share Analysis, By Product
- 9.3 Europe Human Microbiome Market Size and Forecast, By Application
- 9.4 Europe Human Microbiome Market Size and Forecast, By Country
- 9.4.1 Germany
- 9.4.2 France
- 9.4.3 UK
- 9.4.4. Rest of Europe
- 10Asia Pacific Human Microbiome Market Analysis and Forecast (2022 – 2027)
- 10.1 Introduction
- 10.2 Asia Pacific Human Microbiome Market Share Analysis, By Product
- 10.3 Asia Pacific Human Microbiome Market Size and Forecast, By Application
- 10.4 Asia Pacific Human Microbiome Market Size and Forecast, By Country
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4. Rest of Asia Pacific
- 11Latin America Human Microbiome Market Analysis and Forecast (2022 – 2027)
- 11.1 Introduction
- 11.2 Latin America Human Microbiome Market Share Analysis, By Product
- 11.3 Latin America Human Microbiome Market Size and Forecast, By Application
- 11.4 Latin America Human Microbiome Market Size and Forecast, By Country
- 12Middle East Human Microbiome Market Analysis and Forecast (2022 – 2027)
- 12.1 Introduction
- 12.2 Middle East Human Microbiome Market Share Analysis, By Product
- 12.3 Middle East Human Microbiome Market Size and Forecast, By Application
- 12.4 Middle East Human Microbiome Market Size and Forecast, By Country
- 13Competitive Analysis
- 13.1 Competition Dashboard
- 13.2 Market share Analysis of Top Vendors
- 13.3 Key Development Strategies
- 14Company Profiles
- 14.1 Enterome
- 14.1.1 Overview
- 14.1.2 Offerings
- 14.1.3 Key Financials
- 14.1.4 Business Segment & Geographic Overview
- 14.1.5 Key Market Developments
- 14.1.6 Key Strategies
- 14.2 Rebiotix Inc.
- 14.2.1 Overview
- 14.2.2 Offerings
- 14.2.3 Key Financials
- 14.2.4 Business Segment & Geographic Overview
- 14.2.5 Key Market Developments
- 14.2.6 Key Strategies
- 14.3 Yakult Honsha Co., Ltd.
- 14.3.1 Overview
- 14.3.2 Offerings
- 14.3.3 Key Financials
- 14.3.4 Business Segment & Geographic Overview
- 14.3.5 Key Market Developments
- 14.3.6 Key Strategies
- 14.4 Osel Inc.
- 14.4.1 Overview
- 14.4.2 Offerings
- 14.4.3 Key Financials
- 14.4.4 Business Segment & Geographic Overview
- 14.4.5 Key Market Developments
- 14.4.6 Key Strategies
- 14.5 Vedanta Biosciences, Inc.
- 14.5.1 Overview
- 14.5.2 Offerings
- 14.5.3 Key Financials
- 14.5.4 Business Segment & Geographic Overview
- 14.5.5 Key Market Developments
- 14.5.6 Key Strategies
- 14.6Synthetic Biologics, Inc.
- 14.6.1 Overview
- 14.6.2 Offerings
- 14.6.3 Key Financials
- 14.6.4 Business Segment & Geographic Overview
- 14.6.5 Key Market Developments
- 14.6.6 Key Strategies
- 14.7 DuPont
- 14.7.1 Overview
- 14.7.2 Offerings
- 14.7.3 Key Financials
- 14.7.4 Business Segment & Geographic Overview
- 14.7.5 Key Market Developments
- 14.7.6 Key Strategies
- 14.8 BiomX Ltd
- 14.8.1 Overview
- 14.8.2 Offerings
- 14.8.3 Key Financials
- 14.8.4 Business Segment & Geographic Overview
- 14.8.5 Key Market Developments
- 14.8.6 Key Strategies
- 14.9 MaaT Pharma
- 14.9.1 Overview
- 14.9.2 Offerings
- 14.9.3 Key Financials
- 14.9.4 Business Segment & Geographic Overview
- 14.9.5 Key Market Developments
- 14.9.6 Key Strategies
- 14.10 Eligo Bioscience
- 14.10.1 Overview
- 14.10.2 Offerings
- 14.10.3 Key Financials
- 14.10.4 Business Segment & Geographic Overview
- 14.10.5 Key Market Developments
- 14.10.6 Key Strategies
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook